Autolus Therapeutics Statistics
NASDAQ: AUTLHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
1.74-0.07 (-3.87%)
Market open · Delayed 15 min · as of Oct 8, 10:39 AM ET
Autolus Therapeutics by the numbers
Autolus Therapeutics has a market capitalization of $463.1 million based on 266.16M shares outstanding. With trailing EPS of $-1.06, Autolus Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 15.0% below its 50-day average and 3.8% above its 200-day average.
Average daily trading volume is 2.10M shares, or about $3.6 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
AUTL valuation vs. peer median
| Metric | AUTL | Peer median | Difference |
|---|---|---|---|
| Market cap | $463.12M | $430.60M | +8% |
| Avg. volume | 2.10M | 1.01M | +108% |
Peer median across 8 companies: ALLO, RGNX, ENTX, AGMB, TECX, EDIT, VALN, EIKN.
Valuation
- Market cap
- $463.12M
- EPS (TTM)
- $-1.06
- Shares outstanding
- 266.16M
Price and trading
- Previous close
- 1.81
- Open
- 1.78
- Day range
- 1.73 – 1.78
- 52-week range
- 1.18 – 2.58
- 52-week change
- +21.48%
- Beta
- —
- Volume
- 365.99K
- Average volume
- 2.10M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 11, 2026
Additional statistics
- Market Cap
- 463.12M
- Forward Pe
- -2.78
- Eps
- -1.06
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 2.58
- Week52 Low
- 1.18
- Avg Volume
- 2.10M
- Shares Outstanding
- 266.16M
- Ma50
- 2.05
- Ma200
- 1.68
- Earnings Date
- Aug 11, 2026
- Pct From52w High
- -32.56%
- Pct From52w Low
- 48.09%